120 Participants Needed

Airway Protection Rehabilitation for Parkinson's Disease

Recruiting at 1 trial location
MT
Overseen ByMichelle Troche, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Teachers College, Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to find the best way to assist people with Parkinson's Disease (PD) who struggle to protect their airways, potentially leading to serious lung issues. The study will test a new treatment involving Expiratory Muscle Strength Training (EMST) and Cough Skill Training, which are breathing and coughing exercises, delivered either in-person or through telehealth. It seeks participants with PD who have swallowing or coughing difficulties and are not currently receiving exercise-based therapy for swallowing. Participants must live within 1.5 hours of the study locations and meet other specific health criteria. This research aims to make effective treatments more accessible to people with PD. As a Phase 2 trial, it focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to significant advancements in PD care.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that Expiratory Muscle Strength Training (EMST) combined with Cough Skill Training is safe for people with Parkinson's Disease. These treatments improve airway protection without major side effects.

One study found that participants increased their ability to exhale forcefully by 19% after using EMST. This improvement, known as Maximum Expiratory Pressure (MEP), indicates that the treatment is effective and well-tolerated. No serious side effects related to the treatment were reported.

Overall, these findings suggest that this treatment approach is safe for those with Parkinson's Disease. It focuses on strengthening the muscles used for breathing and coughing, which can help prevent issues like aspiration pneumonia.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for Parkinson's disease because they focus on enhancing airway protection, which is a critical issue for many patients. Unlike standard treatments that mainly address motor symptoms, Expiratory Muscle Strength Training coupled with Cough Skill Training targets the muscles involved in breathing and coughing. This approach not only aims to improve respiratory function but also offers the convenience of being delivered in-person or via telehealth, making it accessible to more patients. By strengthening the muscles involved in expiration and coughing, these methods have the potential to significantly reduce the risk of aspiration and related complications.

What evidence suggests that this trial's treatments could be effective for airway protection in Parkinson's Disease?

Research has shown that Expiratory Muscle Strength Training (EMST) can greatly improve breathing and swallowing for people with Parkinson's Disease. Studies have found that EMST strengthens and enhances coughing, which helps protect the airway. This is crucial because problems with airway protection can lead to serious issues like pneumonia, a leading cause of death in people with Parkinson's. In this trial, participants will receive either in-person or telehealth delivery of the combined EMST and Cough Skill Training. Combining EMST with Cough Skill Training might enhance these benefits by teaching patients how to clear their airways better. Early research suggests this combined approach is a promising way to manage airway protection problems in Parkinson's Disease.26789

Who Is on the Research Team?

MT

Michelle Troche, PhD

Principal Investigator

Teachers College, Columbia University

Are You a Good Fit for This Trial?

This trial is for people aged 50-90 with Parkinson's Disease who have trouble swallowing or coughing but aren't currently getting therapy for it. They must be diagnosed by a specialist and can't have other neurological disorders, recent smoking history, breathing diseases, severe depression or dementia.

Inclusion Criteria

I have trouble swallowing thin liquids or coughing effectively.
I have Parkinson's disease, stages II-IV, confirmed by a specialist.
I am not currently undergoing any exercise-based therapy for swallowing.
See 1 more

Exclusion Criteria

I have had head or neck cancer in the past.
My blood pressure is not well-controlled.
I have a history of lung problems like COPD.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intensive Treatment

Participants undergo four weeks of intensive Expiratory Muscle Strength Training (EMST) and Cough Skill Training (CST) delivered in-person or via telehealth

4 weeks
4 visits (in-person or virtual)

Maintenance Treatment

Participants continue with a long-term EMST+CST maintenance program offered in-person or via telehealth

1 year
Assessments at 6 and 12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Expiratory Muscle Strength Training + Cough Skill Training
Trial Overview The study tests whether training to strengthen the muscles used in breathing out and coughing helps protect the airway better than usual care. It compares results of doing these exercises in-person versus via telehealth to see which is more effective.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: TelehealthExperimental Treatment1 Intervention
Group II: In-personActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Teachers College, Columbia University

Lead Sponsor

Trials
27
Recruited
6,100+

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+

Purdue University

Collaborator

Trials
239
Recruited
72,200+

Published Research Related to This Trial

In a study involving 56 participants with Parkinson's Disease, neither expiratory muscle strength training (EMST) nor sensorimotor training of airway protection (smTAP) showed significant changes in vocal fold bowing or the presence of vocal fold lesions, indicating that these treatments do not negatively impact vocal fold health.
Both EMST and smTAP were found to be safe interventions, as they did not lead to the development of vocal fold lesions despite involving forceful exhalation and repetitive coughing.
Cough and Swallowing Therapy and Their Effects on Vocal Fold Bowing and Laryngeal Lesions.Doruk, C., Curtis, JA., Dakin, AE., et al.[2023]
In a study involving 33 participants with Parkinson's disease, the combination of expiratory muscle training (EMT) and air stacking (AS) significantly improved both voluntary and reflex peak cough flow (PCF) compared to EMT alone.
The EMT plus AS group showed a greater enhancement in reflex PCF, indicating that this combined approach may be more effective for improving cough strength in individuals with Parkinson's disease.
Effects of Expiratory Muscle Training and Air Stacking on Peak Cough Flow in Individuals with Parkinson's Disease.Reyes, A., Castillo, A., Castillo, J.[2021]
Expiratory muscle strength training (EMST) is feasible and safe for individuals who have undergone total laryngectomy, with high compliance observed among participants in the study.
While EMST led to improvements in maximum expiratory pressure and vocal loudness, it did not result in significant changes in other pulmonary function or patient-reported outcomes, suggesting further research is needed in a larger group with more pronounced pulmonary issues.
Expiratory Muscle Strength Training in patients After Total Laryngectomy; A Feasibility Pilot Study.van Sluis, KE., Kornman, AF., Groen, WG., et al.[2022]

Citations

Expiratory Muscle Strength Training in Patients with ...Expiratory muscle strength training (EMST) studies have reported significant improvements in maximum expiratory strength, cough efficacy, and swallowing ...
Novel Management of Airway Protection in Parkinson's ...The goal of this study is to determine how well two different rehabilitation treatments, expiratory muscle strength training (EMST) and sensorimotor treatment ...
Impact of Expiratory Muscle Strength Training on Voluntary ...This study demonstrates clear improvement in cough and swallow, as measured by P/A scores, following EMST training, and it shows it is a viable treatment ...
Therapeutic singing and expiratory muscle strength ...The purpose of this study was to understand how two respiratory strengthening protocols, therapeutic singing (TS) and expiratory muscle strength training (EMST ...
Motor Performance During Sensorimotor Training for ...Method: This secondary analysis of treatment data from a randomized con- trolled trial included 28 individuals with PD who participated in five ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/24933728/
Detraining outcomes with expiratory muscle strength training ...Participants demonstrated, on average, a 19% improvement in MEP from pre- to post-EMST. Following the 3 mo detraining period, MEP declined by 2% yet remained 17 ...
Rehabilitation of Airway Protection in Parkinson's Disease... airway protective deficits. Expiratory Muscle Strength Training (EMST) and Cough Skill Training (CST) have been found to improve airway protective disorders ...
Rehabilitating Cough Dysfunction in Parkinson's DiseaseAbbreviations: EMST, expiratory muscle strength training; smTAP, sensorimotor training for airway protection; PAS, Penetration-Aspiration Scale (maximum). 6.
Rehabilitation of Airway Protection in Individuals With ...Detraining outcomes with expiratory muscle strength training in Parkinson disease. Journal of Rehabilitation Research and Development, 51(2) ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity